Inactive Instrument
CannaVEST Corp Stock OTC Bulletin Board
Stocks
US1376531018
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 08-14 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-14 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 3.01M 2.67M 2.5M 2.28M 4.29M 290M 4.35M 30.23M 11.7M 147M 11.29M 11.05M 474M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.73M 4.2M 3.93M 3.58M 6.73M 455M 6.83M 47.49M 18.38M 232M 17.74M 17.36M 744M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
78.62% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CannaVEST Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.97% | -3.61% | +39.13% | +111.91% | 1,025B | |
| -0.92% | -5.35% | +38.03% | +65.46% | 623B | |
| +0.14% | -1.33% | +10.26% | +75.94% | 459B | |
| -0.40% | -3.53% | +60.35% | +39.96% | 355B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 336B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 270B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 247B | |
| -1.21% | -2.70% | +35.64% | +51.48% | 220B | |
| -2.11% | -4.04% | +30.99% | +95.45% | 183B | |
| Average | -1.03% | -1.89% | +27.02% | +56.95% | 413.14B | |
| Weighted average by Cap. | -0.87% | -2.11% | +30.32% | +68.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.95M 13.04M 11.89M 22.38M 1.51B 22.69M 158M 61.09M 770M 58.96M 57.69M 2.47B | 13.79M 12.25M 11.45M 10.44M 19.65M 1.33B 19.92M 139M 53.64M 676M 51.77M 50.65M 2.17B |
| Net income | -2.39M -2.13M -1.99M -1.81M -3.41M -230M -3.46M -24.06M -9.31M -117M -8.99M -8.79M -377M | -958K -851K -796K -725K -1.37M -92.24M -1.38M -9.63M -3.73M -46.97M -3.6M -3.52M -151M |
| Net Debt | 325K 289K 270K 246K 463K 31.29M 469K 3.27M 1.26M 15.94M 1.22M 1.19M 51.19M | 1.72M 1.53M 1.43M 1.3M 2.45M 165M 2.48M 17.26M 6.68M 84.24M 6.45M 6.31M 271M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
